Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.

Read more
Colli Pee Novosanis

Our products

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Learn more
Colli-Pee postal kits for home collection

Home collection

Improving the quality of home-based urine collection by easy self-sampling, alongside postal packaging

Learn more

Latest news

View all news

International Women’s Day

8/03/2022
On International Women’s Day, we celebrate all women in science and health. The OraSure family of companies, including Diversigen, DNA Genotek, and Novosanis, are proud to include a diverse, and international team of women, across various roles and divisions. For this years' blog, we honor all the...
Read more

Latest blogpost

View all blogs

Science banner PMWC

Highlighting our presentations at the Precision Medicine World Conference 2022

29/07/2022
Article by: Sanna Abbasi, PhD, and Arya Mehta Defining precision medicine and its aim Urine as a liquid biopsy for oncology applications - Novosanis OMNIgene™•SKIN: a validated skin microbiome collection system - DNA Genotek OMNIgene™•GUT Dx: a new benchmark for gut microbiome collection - DNA...
Read more

Upcoming event

View all events

AMP 2022 banner

Association for Molecular Pathology 2022 (AMP)

Phoenix, Arizona
We will be at the Association for Molecular Pathology (AMP) 2022 Annual Meeting & Expo, which will take place November 1-5 in Phoenix, Arizona. At the conference, our team can tell you more about the benefits of non-invasive sample types such as urine in oncology and infectious disease testing...
Read more